MedPath

Feasibility of a Patient Directed Tool to Assess Heart Health Among Endometrial Cancer Survivors

Not Applicable
Completed
Conditions
Survivorship
Endometrial Cancer
Interventions
Other: PREVENT Cardiovascular Health Assessment Tool
Other: Survey
Other: Interview Regarding Heart Health
Registration Number
NCT05796518
Lead Sponsor
Wake Forest University Health Sciences
Brief Summary

Investigators are conducting this study to find out more about what heart health means to participants and how healthcare providers can best help to manage heart health. Participants will be asked to view an electronic tool designed to promote heart health awareness and help to manage heart health outside of the clinic. This study will provide important information to help investigators develop future programs that improve cancer patient's heart health after they complete their treatment.

Detailed Description

Primary Objective: The primary objective of this pilot study is to assess the feasibility of enrolling and completing the heart health assessment among endometrial cancer patients scheduled for routine follow-up care.

Secondary Objectives:

* To assess patient satisfaction with the tool.

* To identify the proportion of patients with non-ideal cardiovascular health scores who report initiating discussions regarding cardiovascular health during their routine oncology appointment.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
44
Inclusion Criteria
  • Scheduled for a routine surveillance visit for pathologically confirmed stages I-IV endometrial cancer
  • Greater than or equal to 3 months post-potentially curative cancer treatment
  • Patients must be at least 18 years of age
  • Have a working email address
  • Comfortable reading medical information in English, as per self-report
Exclusion Criteria
  • Currently receiving treatment (e.g. radiation, chemotherapy, immunological treatments for endometrial cancer)
  • Have a history of endometrial cancer recurrence
  • Enrolled in hospice care or documentation of life expectancy < 6 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
PREVENT - Cardiovascular Health Assessment ToolInterview Regarding Heart HealthAn adapted version of the PREVENT tool for endometrial cancer survivors will be used collect data during routine follow-up care for endometrial cancer that will yield a cardiovascular health score based on the Simple 7 risk factors (current smoking habits, body mass index, physical activity, diet, cholesterol, blood pressure and fasting plasma glucose).
PREVENT - Cardiovascular Health Assessment ToolPREVENT Cardiovascular Health Assessment ToolAn adapted version of the PREVENT tool for endometrial cancer survivors will be used collect data during routine follow-up care for endometrial cancer that will yield a cardiovascular health score based on the Simple 7 risk factors (current smoking habits, body mass index, physical activity, diet, cholesterol, blood pressure and fasting plasma glucose).
PREVENT - Cardiovascular Health Assessment ToolSurveyAn adapted version of the PREVENT tool for endometrial cancer survivors will be used collect data during routine follow-up care for endometrial cancer that will yield a cardiovascular health score based on the Simple 7 risk factors (current smoking habits, body mass index, physical activity, diet, cholesterol, blood pressure and fasting plasma glucose).
Primary Outcome Measures
NameTimeMethod
Number of Participants to Complete Intervention - Feasibility6 months

Feasibility will be defined from the number of participants who complete the web-based assessment using exact 95% binomial confidence intervals.

Secondary Outcome Measures
NameTimeMethod
Number of Participants Stating Satisfaction With PREVENT Tool6 months

Patient satisfaction will be identified through post-visit survey with a 5-point Likert scale (strongly agree to strongly disagree) regarding liking the tool, helpfulness, ease of understanding and desire to use this tool with their oncologist. One-sample t-tests will be used to test whether the average response to each question is greater than 3.5 (with three denoting a neutral response). Wilcoxon signed rank tests will be used to compare cancer survivors' knowledge regarding their cardiovascular health risk factors and perceived importance of cancer and heart disease before and after using the cardiovascular risk visualization tool.

Number of Participants to Report Initiating Discussions Regarding Cardiovascular Health With Health Care Providers6 months

The initiation of discussions with participants' health care providers will largely be descriptive (using means as a measurement) to analyze this measure. Participants responded yes/no to the following discussions:

1) Losing weight and maintaining a healthy body weight? 2) Quitting smoking, or staying smoke-free? 3) Controlling your blood pressure? 4) Controlling your cholesterol? 5) Controlling your glucose or hemoglobin A1c? 6) Any discussion regarding health with health care providers

Trial Locations

Locations (1)

Wake Forest Baptist Comprehensive Cancer Center

🇺🇸

Winston-Salem, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath